Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of BYL719 in Combination With Concurrent Cisplatin-based Chemoradiotherapy in Patients With Locoregionally Advanced Squamous Cell Carcinoma of Head and Neck (LA-SCCHN)

NCT02537223 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT02537223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02537223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of BYL719 in Combination With Concurrent Cisplatin-based Chemoradiotherapy in Patients With Locoregionally Advanced Squamous Cell Carcinoma of Head and Neck (LA-SCCHN)
Lead sponsor
University Health Network, Toronto
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2015
Completion date
February 20, 2020
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locoregionally advanced, squamous cell carcinoma of head and neck